WHO ICTRP trial
To investigate whether rinsing the bladder with chemotherapy right before an…
NL-OMON24959 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting
Key facts
| Trial ID | NL-OMON24959 |
|---|---|
| Public title | To investigate whether rinsing the bladder with chemotherapy right before an operation that removes the kidney and ureter because of a malignant tumor is effective to reduce the risk of a subsequent bladder tumor |
| Scientific title | Reduce Bladder Cancer Recurrence In Patients Treated For Upper Urinary Tract Urothelial Carcinoma |
| Primary sponsor | Erasmus university Medical Center |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Conditions | Bladder cancer (blaaskanker), chemotherapy (chemotherapie), nephro-ureterectomy (nefro-ureterectomie), upper urinary tract (hogere urinewegen), urothelial carcinoma (urotheelcelcarcinoom) |
| Interventions | Intravesical instillation with Mitomycin within 3 hours before radical nephroureterectomy or partial ureterectomy. |
| Registration date | Jun 21, 2017 |
| Target size | 170 |
| Secondary IDs | NL6361;NTR6545;NL60919.078.17 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: